Oncologic outcomes after nipple-sparing mastectomy: A single-institution experience

Introduction Long‐term oncologic outcomes in nipple‐sparing mastectomy (NSM) continue to be defined. Rates of locoregional recurrence for skin‐sparing mastectomy (SSM) and NSM in the literature range from 0% to 14.3%. We investigated the outcomes of NSM at our institution. Methods Patients undergoin...

Full description

Saved in:
Bibliographic Details
Published in:Journal of surgical oncology 2016-01, Vol.113 (1), p.8-11
Main Authors: Frey, Jordan D., Alperovich, Michael, Kim, Jennifer Chun, Axelrod, Deborah M., Shapiro, Richard L., Choi, Mihye, Schnabel, Freya R., Karp, Nolan S., Guth, Amber A.
Format: Article
Language:English
Subjects:
Adult
Body Mass Index
breast cancer
Breast Neoplasms - pathology
Breast Neoplasms - surgery
Carcinoma, Ductal, Breast - surgery
Carcinoma, Intraductal, Noninfiltrating - surgery
Female
Humans
locoregional recurrence
Mammaplasty - adverse effects
Mastectomy - methods
Middle Aged
Neoplasm Recurrence, Local - epidemiology
Neoplasm Recurrence, Local - prevention & control
Neoplasm Staging
New York - epidemiology
nipple-sparing mastectomy
Nipples
oncologic
outcomes
Quality of Life
reconstructive
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction Long‐term oncologic outcomes in nipple‐sparing mastectomy (NSM) continue to be defined. Rates of locoregional recurrence for skin‐sparing mastectomy (SSM) and NSM in the literature range from 0% to 14.3%. We investigated the outcomes of NSM at our institution. Methods Patients undergoing NSM at our institution from 2006 to 2014 were identified and outcomes were analyzed. Results From 2006 to 2014, 319 patients (555 breasts) underwent NSM. One‐hundered and fourty‐one patients (237 breasts) had long‐term follow‐up available. Average patient age and BMI were 47.78 and 24.63. Eighty‐four percent of patients underwent mastectomy primarily for a therapeutic indication. Average tumor size was 1.50 cm with the most common histologic type being invasive ductal carcinoma (62.7%) followed by DCIS (23.7%). Average patient follow‐up was 30.73 months. There was one (0.8%) incidence of ipsilateral chest‐wall recurrence. There were 0.37 complications per patient. Conclusions We examined our institutional outcomes with NSM and found a locoregional recurrence rate of 0.8% with no nipple‐areolar complex recurrence. This rate is lower than published rates for both NSM and SSM. J. Surg. Oncol. 2016;113:8–11. © 2015 Wiley Periodicals, Inc.
ISSN:0022-4790
1096-9098
DOI:10.1002/jso.24097